Additionally, ccRCC patients with high intratumoral ITGAE (CD103) expression were found to have significantly shorter overall survival than patients with low ITGAE (CD103) expression within the tumor (Figure 5d). This evidence concerns the gene ITGAE and nonpapillary renal cell carcinoma.